Sign In
Buy SNY
$43.75
-0.230 (-0.523%)
At Close: Jul 21, 2026
Passport to Profits: 7 Global Growth Gems to Diversify Your Holdings
02:52pm, Wednesday, 13'th Mar 2024
While the U.S. is the best block in the neighborhood, sometimes, the area could get a little crowded, which then may offer an opportunity for global growth stocks. No one's saying to avoid American se
Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript)
02:29pm, Tuesday, 12'th Mar 2024
Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript)
Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows
02:00pm, Thursday, 07'th Mar 2024
AstraZeneca and Sanofi's antibody therapy was 90% effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV), a study by the U.S. Centers of Disease Contro
3 Cash Cow Dividend Stocks for Outsized Income & Upside
05:51pm, Tuesday, 27'th Feb 2024
Following another shaky day in the market, investors may want to consider cash cow dividend stocks. They're not sexy and they probably won't make you rich.
Sanofi's consumer healthcare spin-off attracts private equity interest, sources say
11:32am, Tuesday, 20'th Feb 2024
Drugmaker Sanofi's consumer healthcare division has attracted interest from private equity funds as the French group prepares to spin out the business, two sources close to the matter told Reuters.
Blackstone may soon buy Sanofi's consumer health unit
11:19am, Tuesday, 20'th Feb 2024
Sanofi SA (EPA: SAN) is gaining at writing following a report that buyout firms have shown interest in buying its consumer health unit.
Denali-Sanofi's ALS drug fails to meet main goal of mid-stage trial
08:41am, Friday, 16'th Feb 2024
Denali Therapeutics said on Friday it was informed by partner Sanofi that their drug for a type of neurological disease did not meet the main goal in a mid-stage trial.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
07:15am, Friday, 16'th Feb 2024
Not every stock has been swept up in the stock market's euphoria. Shares of Medtronic and Sanofi have been more muted lately.
Sanofi (SNY) Q4 2023 Earnings Call Transcript
02:03pm, Thursday, 01'st Feb 2024
Sanofi (SNY) Q4 2023 Earnings Call Transcript
Sanofi (SNY) Q4 2023 Earnings Call Transcript
02:03pm, Thursday, 01'st Feb 2024
Sanofi (SNY) Q4 2023 Earnings Call Transcript
TEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up
12:56pm, Thursday, 01'st Feb 2024
TEVA reports better-than-expected fourth-quarter results, beating both earnings and sales estimates. The stock gains 3% in response.
Sanofi Q4 earnings burdened by weak dollar, generic competition
01:36am, Thursday, 01'st Feb 2024
Sanofi's fourth-quarter operating income declined 5% as a weaker U.S. dollar and cheaper rivals competing against its established multiple sclerosis drug outweighed growing sales of anti-inflammatory
US FDA approves Dupixent to treat younger kids with esophageal condition
02:48pm, Thursday, 25'th Jan 2024
The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to treat an allergic inflammation of the esophagus in children aged one to 11 years old and weighing at least 15 kg, t
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 24'th Jan 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Sanofi To Acquire Inhibrx in $1.7 Billion Deal To Boost Rare Disease Drugs Pipeline
11:45am, Tuesday, 23'rd Jan 2024
Inhibrx (INBX) shares jumped over 7% in early trading Tuesday after Sanofi (SNY) said it would buy Inhibrx in a $1.7 billion deal as the French pharmaceutical giant expands its pipeline of drugs to tr
